25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biovie Inc
Buy, Hold or Sell?

Let's analyze Biovie Inc together

I guess you are interested in Biovie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biovie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.

1. Quick Overview

1.1. Quick analysis of Biovie Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biovie Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.02
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$0.79
Expected worth in 1 year
$1.16
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$0.39
Return On Investment
14.0%

For what price can you sell your share?

Current Price per Share
$2.76
Expected price per share
$2.33 - $4.77
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biovie Inc (5 min.)




Live pricePrice per Share (EOD)
$2.76
Intrinsic Value Per Share
$-14.44 - $-7.60
Total Value Per Share
$-13.64 - $-6.81

2.2. Growth of Biovie Inc (5 min.)




Is Biovie Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$14m$17.6m-$3.6m-26.2%

How much money is Biovie Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$13.4m$6.8m104.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biovie Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#583 / 945

Most Revenue
#858 / 945

Most Profit
#480 / 945

Most Efficient
#235 / 945
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biovie Inc?

Welcome investor! Biovie Inc's management wants to use your money to grow the business. In return you get a share of Biovie Inc.

First you should know what it really means to hold a share of Biovie Inc. And how you can make/lose money.

Speculation

The Price per Share of Biovie Inc is $2.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovie Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovie Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.79. Based on the TTM, the Book Value Change Per Share is $0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovie Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.23-8.5%-0.37-13.5%-0.47-17.0%-0.70-25.4%-0.39-14.1%
Usd Book Value Change Per Share-0.08-2.9%0.093.3%0.051.9%0.062.3%0.020.7%
Usd Dividend Per Share0.020.7%0.000.2%0.000.0%0.4516.4%0.259.1%
Usd Total Gains Per Share-0.06-2.3%0.103.5%0.051.9%0.5218.8%0.279.8%
Usd Price Per Share1.20-0.85-5.89-6.54-13.68-
Price to Earnings Ratio-1.28--0.64--3.80--6.75--354.87-
Price-to-Total Gains Ratio-19.14--103.82--3.58--33.11--1,039.24-
Price to Book Ratio1.52-1.36-8.86-8.28--11,545.66-
Price-to-Total Gains Ratio-19.14--103.82--3.58--33.11--1,039.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.76
Number of shares362
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.45
Usd Book Value Change Per Share0.090.06
Usd Total Gains Per Share0.100.52
Gains per Quarter (362 shares)34.86187.34
Gains per Year (362 shares)139.44749.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1713312965793739
21326626813131861488
32039840719702792237
42653154626263712986
53366468532834643735
64079782439395574484
74693096345966505233
8531063110252527435982
9601195124159098366731
10661328138065659297480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.044.00.02.2%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%10.028.02.025.0%11.032.02.024.4%
Dividend per Share1.00.03.025.0%1.00.011.08.3%4.00.016.020.0%6.00.034.015.0%6.00.039.013.3%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%9.011.00.045.0%14.025.01.035.0%15.029.01.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biovie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0810.092-188%0.051-257%0.064-226%0.020-513%
Book Value Per Share--0.7920.788+0%0.685+16%0.455+74%0.241+229%
Current Ratio--2.9472.359+25%3.181-7%8.801-67%5.104-42%
Debt To Asset Ratio--0.3380.445-24%0.553-39%1.114-70%1.013-67%
Debt To Equity Ratio--0.5100.921-45%1.332-62%0.970-47%1.795-72%
Dividend Per Share--0.0180.005+300%-+100%0.453-96%0.251-93%
Enterprise Value--34174383.00027735889.155+23%182229364.605-81%148998702.914-77%265475634.661-87%
Eps---0.234-0.372+59%-0.469+101%-0.701+200%-0.390+67%
Ev To Ebitda Ratio---2.226-1.321-41%-3.810+71%-19.502+776%-367.929+16431%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.201-0.272+35%-0.477+137%-0.233+16%-0.122-39%
Free Cash Flow To Equity Per Share---0.215-0.017-92%-0.138-36%66284.068-100%33142.031-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---7.602--------
Intrinsic Value_10Y_min---14.435--------
Intrinsic Value_1Y_max---0.530--------
Intrinsic Value_1Y_min---1.361--------
Intrinsic Value_3Y_max---1.769--------
Intrinsic Value_3Y_min---4.188--------
Intrinsic Value_5Y_max---3.221--------
Intrinsic Value_5Y_min---7.100--------
Market Cap49040232.000+57%21321840.00015054551.655+42%166195742.105-87%140588085.764-85%255199926.695-92%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.486+57%1.5161.365+11%8.863-83%8.279-82%-11545.659+761825%
Pe Ratio-2.953-130%-1.284-0.643-50%-3.802+196%-6.754+426%-354.865+27541%
Price Per Share2.760+57%1.2000.847+42%5.893-80%6.543-82%13.678-91%
Price To Free Cash Flow Ratio-3.425-130%-1.489-0.820-45%-4.145+178%-25.551+1616%-1404.385+94206%
Price To Total Gains Ratio-44.018-130%-19.138-103.824+442%-3.580-81%-33.108+73%-1039.243+5330%
Quick Ratio--2.9282.339+25%3.583-18%8.826-67%5.090-42%
Return On Assets---0.196-0.266+36%-0.362+85%-1.611+724%-0.940+381%
Return On Equity---0.295-0.552+87%-0.860+191%-1.826+519%-1.310+344%
Total Gains Per Share---0.0630.096-165%0.051-222%0.518-112%0.270-123%
Usd Book Value--14067085.00013997615.500+0%17668634.000-20%10039318.650+40%5254892.175+168%
Usd Book Value Change Per Share---0.0810.092-188%0.051-257%0.064-226%0.020-513%
Usd Book Value Per Share--0.7920.788+0%0.685+16%0.455+74%0.241+229%
Usd Dividend Per Share--0.0180.005+300%-+100%0.453-96%0.251-93%
Usd Enterprise Value--34174383.00027735889.155+23%182229364.605-81%148998702.914-77%265475634.661-87%
Usd Eps---0.234-0.372+59%-0.469+101%-0.701+200%-0.390+67%
Usd Free Cash Flow---3579456.000-4836857.750+35%-10802402.500+202%-5112928.600+43%-2664670.075-26%
Usd Free Cash Flow Per Share---0.201-0.272+35%-0.477+137%-0.233+16%-0.122-39%
Usd Free Cash Flow To Equity Per Share---0.215-0.017-92%-0.138-36%66284.068-100%33142.031-100%
Usd Market Cap49040232.000+57%21321840.00015054551.655+42%166195742.105-87%140588085.764-85%255199926.695-92%
Usd Price Per Share2.760+57%1.2000.847+42%5.893-80%6.543-82%13.678-91%
Usd Profit---4152032.000-6612131.000+59%-13489117.500+225%-12942215.000+212%-6739379.000+62%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.0630.096-165%0.051-222%0.518-112%0.270-123%
 EOD+5 -3MRQTTM+25 -9YOY+17 -175Y+17 -1710Y+13 -21

3.3 Fundamental Score

Let's check the fundamental score of Biovie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.953
Price to Book Ratio (EOD)Between0-13.486
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.928
Current Ratio (MRQ)Greater than12.947
Debt to Asset Ratio (MRQ)Less than10.338
Debt to Equity Ratio (MRQ)Less than10.510
Return on Equity (MRQ)Greater than0.15-0.295
Return on Assets (MRQ)Greater than0.05-0.196
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.624
Ma 20Greater thanMa 503.077
Ma 50Greater thanMa 1002.420
Ma 100Greater thanMa 2002.685
OpenGreater thanClose2.970
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biovie Inc

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Fundamental data was last updated by Penke on 2024-12-05 13:56:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biovie Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.4%+109.4%
TTM--221.4%+221.4%
YOY--208.7%+208.7%
5Y--346.2%+346.2%
10Y--470.4%+470.4%
4.3.1.2. Return on Assets

Shows how efficient Biovie Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -19.6% Return on Assets means that Biovie Inc generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovie Inc:

  • The MRQ is -19.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.6%TTM-26.6%+7.1%
TTM-26.6%YOY-36.2%+9.6%
TTM-26.6%5Y-161.1%+134.5%
5Y-161.1%10Y-94.0%-67.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.6%-11.6%-8.0%
TTM-26.6%-12.0%-14.6%
YOY-36.2%-11.2%-25.0%
5Y-161.1%-12.6%-148.5%
10Y-94.0%-14.2%-79.8%
4.3.1.3. Return on Equity

Shows how efficient Biovie Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -29.5% Return on Equity means Biovie Inc generated $-0.30 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovie Inc:

  • The MRQ is -29.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -55.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.5%TTM-55.2%+25.7%
TTM-55.2%YOY-86.0%+30.8%
TTM-55.2%5Y-182.6%+127.3%
5Y-182.6%10Y-131.0%-51.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.5%-14.5%-15.0%
TTM-55.2%-16.0%-39.2%
YOY-86.0%-14.6%-71.4%
5Y-182.6%-18.6%-164.0%
10Y-131.0%-19.3%-111.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biovie Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biovie Inc is operating .

  • Measures how much profit Biovie Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--203.3%+203.3%
TTM--316.3%+316.3%
YOY--216.5%+216.5%
5Y--378.6%+378.6%
10Y--480.3%+480.3%
4.3.2.2. Operating Ratio

Measures how efficient Biovie Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biovie Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.284-2.284
TTM-3.198-3.198
YOY-3.263-3.263
5Y-4.651-4.651
10Y-6.419-6.419
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biovie Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biovie Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.95 means the company has $2.95 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovie Inc:

  • The MRQ is 2.947. The company is able to pay all its short-term debts. +1
  • The TTM is 2.359. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.947TTM2.359+0.588
TTM2.359YOY3.181-0.822
TTM2.3595Y8.801-6.442
5Y8.80110Y5.104+3.697
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9473.601-0.654
TTM2.3593.872-1.513
YOY3.1814.655-1.474
5Y8.8015.973+2.828
10Y5.1046.258-1.154
4.4.3.2. Quick Ratio

Measures if Biovie Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2.93 means the company can pay off $2.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovie Inc:

  • The MRQ is 2.928. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.339. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.928TTM2.339+0.589
TTM2.339YOY3.583-1.244
TTM2.3395Y8.826-6.487
5Y8.82610Y5.090+3.736
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9283.093-0.165
TTM2.3393.416-1.077
YOY3.5834.393-0.810
5Y8.8265.954+2.872
10Y5.0906.436-1.346
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biovie Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biovie Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biovie Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34 means that Biovie Inc assets are financed with 33.8% credit (debt) and the remaining percentage (100% - 33.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biovie Inc:

  • The MRQ is 0.338. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.445. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.445-0.107
TTM0.445YOY0.553-0.109
TTM0.4455Y1.114-0.669
5Y1.11410Y1.013+0.100
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3380.345-0.007
TTM0.4450.346+0.099
YOY0.5530.311+0.242
5Y1.1140.365+0.749
10Y1.0130.382+0.631
4.5.4.2. Debt to Equity Ratio

Measures if Biovie Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 51.0% means that company has $0.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovie Inc:

  • The MRQ is 0.510. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.921. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.510TTM0.921-0.411
TTM0.921YOY1.332-0.411
TTM0.9215Y0.970-0.049
5Y0.97010Y1.795-0.825
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5100.393+0.117
TTM0.9210.431+0.490
YOY1.3320.384+0.948
5Y0.9700.452+0.518
10Y1.7950.497+1.298
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biovie Inc generates.

  • Above 15 is considered overpriced but always compare Biovie Inc to the Biotechnology industry mean.
  • A PE ratio of -1.28 means the investor is paying $-1.28 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovie Inc:

  • The EOD is -2.953. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.284. Based on the earnings, the company is expensive. -2
  • The TTM is -0.643. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.953MRQ-1.284-1.669
MRQ-1.284TTM-0.643-0.641
TTM-0.643YOY-3.802+3.158
TTM-0.6435Y-6.754+6.111
5Y-6.75410Y-354.865+348.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.953-2.259-0.694
MRQ-1.284-2.480+1.196
TTM-0.643-3.148+2.505
YOY-3.802-3.244-0.558
5Y-6.754-5.991-0.763
10Y-354.865-6.692-348.173
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovie Inc:

  • The EOD is -3.425. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.489. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.820. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.425MRQ-1.489-1.936
MRQ-1.489TTM-0.820-0.669
TTM-0.820YOY-4.145+3.325
TTM-0.8205Y-25.551+24.730
5Y-25.55110Y-1,404.385+1,378.834
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.425-2.995-0.430
MRQ-1.489-3.289+1.800
TTM-0.820-3.668+2.848
YOY-4.145-4.472+0.327
5Y-25.551-8.001-17.550
10Y-1,404.385-9.190-1,395.195
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biovie Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.52 means the investor is paying $1.52 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovie Inc:

  • The EOD is 3.486. Based on the equity, the company is fair priced.
  • The MRQ is 1.516. Based on the equity, the company is underpriced. +1
  • The TTM is 1.365. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.486MRQ1.516+1.970
MRQ1.516TTM1.365+0.151
TTM1.365YOY8.863-7.498
TTM1.3655Y8.279-6.914
5Y8.27910Y-11,545.659+11,553.938
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4862.001+1.485
MRQ1.5162.054-0.538
TTM1.3652.385-1.020
YOY8.8632.431+6.432
5Y8.2793.690+4.589
10Y-11,545.6594.307-11,549.966
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biovie Inc.

4.8.1. Institutions holding Biovie Inc

Institutions are holding 9.989% of the shares of Biovie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Group Inc0.3199056837568370
2024-09-30Geode Capital Management, LLC0.2148038174381740
2024-09-30Zullo Investment Group, Inc.0.14070.012525000250000
2024-09-30HPM Partners LLC0.0970.000117230172300
2024-09-30United Capital Management of KS0.05630.002610000100000
2024-09-30Tower Research Capital LLC0.01850.0001328232820
2024-09-30Morgan Stanley - Brokerage Accounts0.01550276127610
2024-09-30Newbridge Financial Services Group, Inc.0.00790.0006140014000
2024-06-30SIMPLEX TRADING, LLC0.00080133813380
2024-06-30Steward Partners Investment Advisory, LLC0.00060100000
2024-09-30Wells Fargo & Co0.003105505500
2024-06-30CWM, LLC duplicate0.000102152150
2024-09-30Goss Wealth Management LLC0.000601001000
2024-09-30Flaharty Asset Management, LLC0.000601001000
2024-09-30JPMorgan Chase & Co0.0004077770
2024-09-30Financial Perspectives Inc0.0003059590
2024-09-30UBS Group AG0.0003045450
2024-06-30New York State Common Retirement Fund0035350
2024-09-30HARBOUR INVESTMENTS, INC.0.000203000
2024-09-30JAFFETILCHIN INVESTMENT PARTNERS, LLC0.0001021210
Total 0.87770.0159158254+157224+99.3%

4.9.2. Funds holding Biovie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Belfund SICAV Belinvest Equity A USD Acc0.56280.161710000000
2024-10-31Vanguard Total Stock Mkt Idx Inv0.233604150900
2024-09-30Fidelity Extended Market Index0.12550.000122305560933.5949
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.083101476400
2024-09-30Fidelity Series Total Market Index0.029051583709255.9696
2024-09-30Fidelity Nasdaq Composite Index0.02570457300
2024-09-30Spartan Extended Market Index Pool E0.01980.0001351535150
2024-09-30Fidelity Total Market Index0.01040185500
2024-09-30NT Ext Equity Mkt Idx Fd - L0.00730129300
2024-09-30Northern Trust Extended Eq Market Idx0.00730129300
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.00590104310.096
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0047084030.3584
2024-09-30Spartan Total Market Index Pool E0.0043076100
2024-10-31Vanguard U.S. Eq Idx £ Acc0.0032056400
2024-06-30SSgA U.S. Total Market Index Strategy0.0002041012242.3611
2024-09-30BNYM Mellon SL Market Completion UC10.00160.000128800
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0011020000
2024-06-30Russell Personalized DI Core Equity0.0001017721.1429
2024-10-31State St US Extended Mkt Indx NL Cl C0.0006010000
2024-09-30Northern Trust Wilshire 50000.000508900
Total 1.12670.162200737+12961+6.5%

5.3. Insider Transactions

Insiders are holding 13.692% of the shares of Biovie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-30Cuong V DoBUY100001.78
2023-09-05Steve GorlinSELL85603.05
2023-08-22Richard J BermanSELL108053.5
2023-06-07Richard J BermanSELL59845.81
2023-05-22Richard J BermanSELL50006.5
2023-03-27Richard J BermanSELL33718.52
2021-12-07Joanne Wendy KimBUY20005.4
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. All numbers in thousands.

Summary
Total Assets21,238
Total Liabilities7,171
Total Stockholder Equity14,067
 As reported
Total Liabilities 7,171
Total Stockholder Equity+ 14,067
Total Assets = 21,238

Assets

Total Assets21,238
Total Current Assets20,151
Long-term Assets1,087
Total Current Assets
Cash And Cash Equivalents 20,023
Other Current Assets 128
Total Current Assets  (as reported)20,151
Total Current Assets  (calculated)20,151
+/-0
Long-term Assets
Property Plant Equipment 391
Goodwill 346
Intangible Assets 350
Long-term Assets  (as reported)1,087
Long-term Assets  (calculated)1,087
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,838
Long-term Liabilities333
Total Stockholder Equity14,067
Total Current Liabilities
Short-term Debt 3,384
Other Current Liabilities 3,454
Total Current Liabilities  (as reported)6,838
Total Current Liabilities  (calculated)6,838
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)333
Long-term Liabilities  (calculated)0
+/- 333
Total Stockholder Equity
Common Stock6
Retained Earnings -338,710
Other Stockholders Equity 352,770
Total Stockholder Equity (as reported)14,067
Total Stockholder Equity (calculated)14,067
+/-0
Other
Cash and Short Term Investments 20,023
Common Stock Shares Outstanding 6,398
Liabilities and Stockholders Equity 21,238
Net Debt -16,307
Net Working Capital 13,313
Short Long Term Debt Total 3,717



5.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
446
407
360
333
318
293
282
269
269
250
233
2,719
2,540
2,478
2,452
2,364
2,323
2,246
2,215
2,175
2,175
3,645
2,964
2,574
2,608
2,340
2,309
2,084
14,861
13,460
12,893
6,047
21,978
31,873
26,188
20,115
22,859
47,192
45,183
35,105
23,760
21,490
31,773
25,208
21,238
21,23825,20831,77321,49023,76035,10545,18347,19222,85920,11526,18831,87321,9786,04712,89313,46014,8612,0842,3092,3402,6082,5742,9643,6452,1752,1752,2152,2462,3232,3642,4522,4782,5402,7192332502692692822933183333604074460
   > Total Current Assets 
0
446
407
360
333
318
293
282
269
269
250
233
131
9
5
35
5
22
2
28
46
46
1,630
1,007
674
765
554
581
413
13,248
11,903
11,394
4,605
20,594
30,547
24,792
18,780
21,590
45,990
44,047
34,041
22,764
20,562
30,540
24,048
20,151
20,15124,04830,54020,56222,76434,04144,04745,99021,59018,78024,79230,54720,5944,60511,39411,90313,2484135815547656741,0071,630464628222535591312332502692692822933183333604074460
       Cash And Cash Equivalents 
0
446
407
345
333
318
288
279
267
267
250
233
124
9
5
35
5
22
2
28
46
46
1,630
972
340
249
3
4
37
13,196
11,876
11,351
4,512
20,488
30,392
24,507
18,642
21,231
45,749
31,276
19,461
21,215
20,227
30,350
23,844
20,023
20,02323,84430,35020,22721,21519,46131,27645,74921,23118,64224,50730,39220,4884,51211,35111,87613,19637432493409721,630464628222535591242332502672672792883183333454074460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,521
14,478
0
0
0
0
0
0000014,47812,521000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
14
0
0
5
4
2
2
0
0
7
0
0
0
0
0
0
0
0
0
0
35
334
516
551
577
376
52
27
43
93
106
155
285
138
359
241
250
103
1,549
335
190
204
128
1282041903351,5491032502413591382851551069343275237657755151633435000000000070022450014000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
2,531
2,474
2,416
2,359
2,302
2,244
2,187
0
2,130
2,015
1,958
1,900
1,843
1,786
1,728
1,671
1,614
1,556
1,499
1,442
1,384
1,327
1,397
1,335
1,269
1,202
1,135
1,064
996
929
1,233
1,160
1,087
1,0871,1601,2339299961,0641,1351,2021,2691,3351,3971,3271,3841,4421,4991,5561,6141,6711,7281,7861,8431,9001,9582,0152,13002,1872,2442,3022,3592,4162,4742,5312,588000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
118
109
100
91
81
71
60
422
407
391
3914074226071819110010911812700000000000000000000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,243
2,185
2,128
2,071
2,013
1,956
1,899
1,841
1,784
1,784
1,669
1,612
1,555
1,497
1,440
1,383
1,325
1,268
1,211
1,153
1,096
1,039
981
924
866
809
752
694
637
580
522
465
408
350
3504084655225806376947528098669249811,0391,0961,1531,2111,2681,3251,3831,4401,4971,5551,6121,6691,7841,7841,8411,8991,9562,0132,0712,1282,1852,243000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
0
0
0
0
0
0
0
0000000555000000000000000000000000000000000000
> Total Liabilities 
0
9
17
3
161
204
247
283
324
324
404
445
803
961
1,151
979
1,207
1,241
1,455
1,660
2,064
2,064
105
179
443
11,329
4,384
4,654
23,583
266
385
1,491
996
1,744
15,808
16,234
16,444
16,898
21,124
23,464
19,764
16,212
13,999
12,847
9,702
7,171
7,1719,70212,84713,99916,21219,76423,46421,12416,89816,44416,23415,8081,7449961,49138526623,5834,6544,38411,3294431791052,0642,0641,6601,4551,2411,2079791,15196180344540432432428324720416131790
   > Total Current Liabilities 
0
9
17
3
161
204
247
283
324
324
404
445
803
961
1,151
403
631
665
879
1,084
1,238
1,238
105
179
443
11,329
4,384
4,654
23,520
203
322
1,428
996
1,260
4,358
4,317
4,169
4,096
7,797
16,004
14,495
13,212
13,981
12,481
9,352
6,838
6,8389,35212,48113,98113,21214,49516,0047,7974,0964,1694,3174,3581,2609961,42832220323,5204,6544,38411,3294431791051,2381,2381,0848796656314031,15196180344540432432428324720416131790
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
25
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
29
39
40
42
6,434
9,150
9,385
10,244
8,050
5,762
3,384
3,3845,7628,05010,2449,3859,1506,43442403929000000849473522000002557610347102100000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
601
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
0
0
0
0
6,391
9,105
9,339
10,195
7,993
0
0
007,99310,1959,3399,1056,39100000000008494735220000060157610347102100000000000000
       Accounts payable 
0
9
0
3
0
2
5
1
1
1
1
1
294
389
517
330
471
468
629
746
884
884
105
179
443
684
1,085
1,300
1,259
203
322
1,428
996
679
1,663
1,206
2
3
3,245
5
3
3
4
4,410
3,587
0
03,5874,41043353,245321,2061,6636799961,4283222031,2591,3001,085684443179105884884746629468471330517389294111115203090
       Other Current Liabilities 
0
0
17
0
161
202
242
283
323
323
404
444
510
572
635
73
160
198
879
0
0
354
0
0
0
11,327
3,247
4,181
21,412
0
0
0
996
1,260
4,358
4,288
4,130
4,055
4,510
9,570
5,345
3,827
3,734
21
4
3,454
3,4544213,7343,8275,3459,5704,5104,0554,1304,2884,3581,26099600021,4124,1813,24711,327000354008791981607363557251044440432332328324220216101700
   > Long-term Liabilities 
0
9
0
3
0
2
5
1
0
1
1
1
0
389
517
576
576
576
576
576
0
826
105
179
443
2
1,137
473
63
63
63
63
0
484
11,450
11,916
12,274
12,802
13,327
7,460
5,270
3,000
18
366
350
333
333350366183,0005,2707,46013,32712,80212,27411,91611,4504840636363634731,137244317910582605765765765765765173890111015203090
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
63
0
0
0
0
12,139
12,725
13,261
0
0
0
0
0
0
0
000000013,26112,72512,13900006363000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
576
576
576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
484
339
194
48
0
0
0
0
0
0
0
0
0
00000000048194339484000000000000000576576576000000000000000
> Total Stockholder Equity
0
437
390
357
171
115
46
-1
-54
-54
-155
-211
1,916
1,578
1,327
1,473
1,157
1,082
791
555
111
111
3,541
2,785
2,131
-8,721
-2,044
-2,344
-21,499
14,596
13,075
11,402
5,050
20,234
16,065
9,955
3,671
5,961
26,068
21,718
15,340
7,548
7,491
18,926
15,506
14,067
14,06715,50618,9267,4917,54815,34021,71826,0685,9613,6719,95516,06520,2345,05011,40213,07514,596-21,499-2,344-2,044-8,7212,1312,7853,5411111115557911,0821,1571,4731,3271,5781,916-211-155-54-54-1461151713573904370
   Common Stock
0
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
10
32
32
51
65
1
1
1
1
1
1
2
2
2
2
2
3
3
4
4
4
4
6
6
6
66644443322222111111655132321010109999999999999999990
   Retained Earnings Total Equity0000000-277,073-261,386-250,9700000-93,353-90,360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
177
0
0
0
0
0
0000017717000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,434
104,754
0
0
0
0
254,638
267,344
303,137
0
0
0
0
0
0
0
0000000303,137267,344254,6380000104,754103,434000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
500
500
514
502
504
506
508
510
510
513
514
2,912
2,925
3,032
3,356
3,483
4,071
4,282
4,739
0
4,870
9,267
9,360
9,342
19,397
19,472
19,539
19,539
101,897
103,434
104,754
229,934
250,658
251,903
252,833
254,638
267,344
303,137
313,812
316,386
319,480
327,825
348,212
349,733
352,770
352,770349,733348,212327,825319,480316,386313,812303,137267,344254,638252,833251,903250,658229,934104,754103,434101,89719,53919,53919,47219,3979,3429,3609,2674,87004,7394,2824,0713,4833,3563,0322,9252,9125145135105105085065045025145005000



5.3. Balance Sheets

All numbers in thousands.




5.4. Cash Flows

All numbers in thousands.




5.5. Income Statements

All numbers in thousands.